Postoperative Residuals and Relapsing of Primary Liver Carcinoma Treated by Chinese Drugs and Chinese Drugs Plus Chemotherapy

doi:10.13288/j.11-2166/r.1994.04.021

您当前的位置：

首页 >

文章列表页 >

Postoperative Residuals and Relapsing of Primary Liver Carcinoma Treated by Chinese Drugs and Chinese Drugs Plus Chemotherapy

更新时间：2021-11-20

- Postoperative Residuals and Relapsing of Primary Liver Carcinoma Treated by Chinese Drugs and Chinese Drugs Plus Chemotherapy
- Journal of Traditional Chinese Medicine Issue 4, Pages: 220-221(1994)
- 作者机构：
  
  1. 上海医科大学附属肿瘤医院中医科
  2. 上海医科大学附属肿瘤医院中医科上海市零陵路399号,200032
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.1994.04.021
  CLC： R273
- Published：1994
- 稿件说明：
移动端阅览
[1]林钧华,徐益语,于尔辛.中药及中药结合放化疗治疗原发性肝癌术后残留和复发[J].中医杂志,1994(04):220-221+196.

Postoperative Residuals and Relapsing of Primary Liver Carcinoma Treated by Chinese Drugs and Chinese Drugs Plus Chemotherapy[J]. Journal of Traditional Chinese Medicine1994, (4): 220-221.
[1]林钧华,徐益语,于尔辛.中药及中药结合放化疗治疗原发性肝癌术后残留和复发[J].中医杂志,1994(04):220-221+196. DOI： 10.13288/j.11-2166/r.1994.04.021.

Postoperative Residuals and Relapsing of Primary Liver Carcinoma Treated by Chinese Drugs and Chinese Drugs Plus Chemotherapy[J]. Journal of Traditional Chinese Medicine1994, (4): 220-221. DOI： 10.13288/j.11-2166/r.1994.04.021.

摘要

应用中药及中药结合放化疗治疗110例原发性肝癌术后残留和复发、转移患者

中药以健脾理气、疏肝解郁、化湿和中、益气养血药物为主。结果表明

110例患者中

1年生存率为70.78±8.53％

3年生存率为33.82±9.25％

5年生存率为16±7.43％（寿命表法）

有4例已生存10年以上。提示以扶正健脾为主的治疗原则对原发性肝癌术后延长生存期有重要意义。

Abstract

One hundred and ten caese of postoperative residuals

relapsing and metastasisin primary liver carcinoma were treated by traditional drugs and traditional drug plus chemotherapy. The drugs were of strengthening spleen

regulating Qi

dispersing Liver

relieving stagnation

dissipating dampness

mediating the stomach and spleen

invigoating Qi and replenishing blood. Results revealedthat the 1-year survival rate in 110 cases was 70. 78+8. 53%

3 -year survival rate was 33. 82+9. 25%

5-year survival rate was 16+7. 43% （by list of life - spanmethod）. Among them

4 cases have survived for over 10 years

indicating that the treating principles of supporting the body resistance and strengthening the spleen is significant in prolonging the survival rate of primary liver card-norna after operation.

关键词

Keywords

references

查看原文

Views

166

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

基于“肝主生发”从肝论治肿瘤的复发与转移

TCM Theory of Carcinomatous Toxin Metastasis

Action of Remedies of Supporting Resistance and Relieving Blood Stasis on Metastasis of Post-operative Gastric Cancer and Its Influence on Ornithine Decarboxylase,

Challenges and Recommendations for Implementing Key Technologies in Decentralized Clinical Trials of Traditional Chinese Medicine

Syndrome Differentiation and Treatment of Cholinergic Urticaria from the Perspective of "Treating Fire Constraint by Dispersing It"

Related Author

杨永

王笑民

YE Naijing

LIU Xuan

LI Qi

卜平

Related Institution

首都医科大学附属北京中医医院，北京市东城区美术馆后街23号

Shuguang Hospital, Shanghai University of Traditional Chinese Medicine

扬州大学医学院江苏省扬州市淮海路6号

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰